Literature DB >> 21987769

DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.

Reed S Shabman1, Daisy W Leung, Joshua Johnson, Nicole Glennon, Erol E Gulcicek, Kathryn L Stone, Lawrence Leung, Lisa Hensley, Gaya K Amarasinghe, Christopher F Basler.   

Abstract

The Zaire Ebola virus (EBOV) protein VP35 is multifunctional; it inhibits IFN-α/β production and functions as a cofactor of the viral RNA polymerase. Mass spectrometry identified the double stranded RNA binding protein 76 (DRBP76/NFAR-1/NF90) as a cellular factor that associates with the VP35 C-terminal interferon inhibitory domain (IID). DRBP76 is described to regulate host cell protein synthesis and play an important role in host defense. The VP35-IID-DRBP76 interaction required the addition of exogenous dsRNA, but full-length VP35 associated with DRBP76 in the absence of exogenous dsRNA. Cells infected with a Newcastle disease virus (NDV)-expressing VP35 redistributed DRBP76 from the nucleus to the cytoplasm, the compartment in which EBOV replicates. Overexpression of DRBP76 did not alter the ability of VP35 to inhibit type I IFN production but did impair the function of the EBOV transcription/replication complex. These data suggest that DRBP76, via its association with VP35, exerts an anti-EBOV function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987769      PMCID: PMC3218669          DOI: 10.1093/infdis/jir343

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Host cell proteins binding to the encapsidation signal epsilon in hepatitis B virus RNA.

Authors:  H J Shin; S S Kim; Y H Cho; S G Lee; H M Rho
Journal:  Arch Virol       Date:  2002-03       Impact factor: 2.574

2.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.

Authors:  Amy L Hartman; Jonathan S Towner; Stuart T Nichol
Journal:  Virology       Date:  2004-10-25       Impact factor: 3.616

4.  Interactions of Marburg virus nucleocapsid proteins.

Authors:  S Becker; C Rinne; U Hofsäss; H D Klenk; E Mühlberger
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

5.  Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes.

Authors:  E Mühlberger; B Lötfering; H D Klenk; S Becker
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins.

Authors:  H J Liao; R Kobayashi; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.

Authors:  Lawrence W Leung; Man-Seong Park; Osvaldo Martinez; Charalampos Valmas; Carolina B López; Christopher F Basler
Journal:  Immunol Cell Biol       Date:  2011-01-25       Impact factor: 5.126

8.  The 90- and 110-kDa human NFAR proteins are translated from two differentially spliced mRNAs encoded on chromosome 19p13.

Authors:  L R Saunders; V Jurecic; G N Barber
Journal:  Genomics       Date:  2001-01-15       Impact factor: 5.736

9.  Members of the NF90/NFAR protein group are involved in the life cycle of a positive-strand RNA virus.

Authors:  Olaf Isken; Claus W Grassmann; Robert T Sarisky; Michael Kann; Suisheng Zhang; Frank Grosse; Peter N Kao; Sven-Erik Behrens
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

Authors:  Christopher F Basler; Andrea Mikulasova; Luis Martinez-Sobrido; Jason Paragas; Elke Mühlberger; Mike Bray; Hans-Dieter Klenk; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  21 in total

1.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

2.  DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome.

Authors:  Kei Takahashi; Peter Halfmann; Masaaki Oyama; Hiroko Kozuka-Hata; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.

Authors:  Parameshwaran Ramanan; Megan R Edwards; Reed S Shabman; Daisy W Leung; Ariel C Endlich-Frazier; Dominika M Borek; Zbyszek Otwinowski; Gai Liu; Juyoung Huh; Christopher F Basler; Gaya K Amarasinghe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

4.  Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Authors:  Priya Luthra; Parameshwaran Ramanan; Chad E Mire; Carla Weisend; Yoshimi Tsuda; Benjamin Yen; Gai Liu; Daisy W Leung; Thomas W Geisbert; Hideki Ebihara; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

5.  Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions.

Authors:  Emily V Nelson; Kristina M Schmidt; Laure R Deflubé; Sultan Doğanay; Logan Banadyga; Judith Olejnik; Adam J Hume; Elena Ryabchikova; Hideki Ebihara; Nancy Kedersha; Taekjip Ha; Elke Mühlberger
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.

Authors:  Jane Murphy; William W Hall; Lee Ratner; Noreen Sheehy
Journal:  Virology       Date:  2016-04-22       Impact factor: 3.616

7.  The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.

Authors:  Preeti Bharaj; Colm Atkins; Priya Luthra; Maria Isabel Giraldo; Brian E Dawes; Lisa Miorin; Jeffrey R Johnson; Nevan J Krogan; Christopher F Basler; Alexander N Freiberg; Ricardo Rajsbaum
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

8.  Heterogeneous nuclear ribonucleoprotein K supports vesicular stomatitis virus replication by regulating cell survival and cellular gene expression.

Authors:  Phat X Dinh; Anshuman Das; Rodrigo Franco; Asit K Pattnaik
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

9.  An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression.

Authors:  Jérôme Barbier; Xin Chen; Gabriel Sanchez; Muyan Cai; Marion Helsmoortel; Takuma Higuchi; Pierre Giraud; Xavier Contreras; Gangjun Yuan; Zihao Feng; Rima Nait-Saidi; Olivier Deas; Lisa Bluy; Jean-Gabriel Judde; Sylvie Rouquier; William Ritchie; Shuji Sakamoto; Dan Xie; Rosemary Kiernan
Journal:  Cell Res       Date:  2018-03-21       Impact factor: 25.617

10.  The NF45/NF90 Heterodimer Contributes to the Biogenesis of 60S Ribosomal Subunits and Influences Nucleolar Morphology.

Authors:  Franziska Wandrey; Christian Montellese; Krisztian Koos; Lukas Badertscher; Lukas Bammert; Atlanta G Cook; Ivo Zemp; Peter Horvath; Ulrike Kutay
Journal:  Mol Cell Biol       Date:  2015-08-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.